Home > Press > Appointment of LITMUS Defense CEO to Nanotechnology Board
LITMUS, LLC, a leading global technology innovations company, today announces that Bill Nevius, President and CEO of its wholly owned subsidiary, LITMUS Defense LLC, has been selected to join the Board of Directors of the Colorado Nanotechnology Alliance for 2007.
Appointment of LITMUS Defense CEO to Nanotechnology Board
Houston, TX | Posted on February 9th, 2007
The Alliance is a non-for-profit corporation established in 2006 to advance economic development in the State of Colorado, with a focus on the use of nanotechnology. The Alliance partners with universities, industry, and government to advance Colorado's economic development efforts in five nanotechnology related target areas: leadership, business growth, research and technology transfer, workforce development, and public education and societal change.
Bill Nevius has close to thirty years' experience in the aerospace industry. As a US government acquisition professional he is certified in program management, systems engineering and test and evaluation, and is recognized as an expert in related technology transfers. Bill has also held senior management and executive level positions at Ball Aerospace & Technologies Corp., Avtec Systems Inc., and Wave Technologies Inc. Bill earned a BSc in Mechanical Engineering and an MSc in Aeronautical Engineering and is also a certified Naval Test Pilot.
Mark Diggs, Chief Executive Officer of LITMUS, commented: "We are honored that Bill will be representing LITMUS on the Board of an organization that is such a strong advocate for technology. Our robust portfolio of companies has evolved from a tried and tested methodology and we look forward to offering our support and further help to the Alliance."
Debbie Woodward, Executive Director of the Alliance said: "We are delighted that LITMUS will be represented on our Board both because of the Company's strong nanotechnology expertise and also of its experience and vision in the development, transition and commercialisation of such technology. The US National Science Foundation predicts nanotechnology will produce a US$1 trillion global market by 2015 and we intend to ensure Colorado, with LITMUS' help, is at the forefront of such developments."
LITMUS, LLC is a global technology innovator which identifies disruptive technologies and services that can provide unique commercial solutions to significant unmet market needs. The Company's alternative approach to traditional funding and business development models enables it to then create revolutionary technology companies before scaling each one towards a liquidity event.
The LITMUS management team has rigorously applied its business methodology to create the following portfolio of divisions and subsidiaries: LITMUS nanoTechnology, LITMUS FQI, LITMUS RAPID-B and LITMUS Molecular Design. LITMUS has also created two subsidiaries that complement the Company's technology portfolio and enhance the execution of LITMUS' business methodology in LITMUS Defense and LITMUS Consulting.
About LITMUS, LLC
Founded in 2002, LITMUS, LLC is headquartered in Little Rock, Arkansas USA, and has offices across America and in London, England.
For more information, please click here
9821 Katy Freeway
Mark Diggs, Chief Executive Officer
Tel: +1 713 464 7770
For media enquiries:
Tel: +44 (0) 20 7398 7700
Copyright © LITMUS, LLC
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Promising use of nanodiamonds in delivering cancer drug to kill cancer stem cells: NUS study shows that delivery of Epirubicin by nanodiamonds resulted in a normally lethal dosage of Epirubicin becoming a safe and effective dosage for treatment of liver cancer January 26th, 2015
GS7 Graphene Sensor maybe Solution in Fight Against Cancer January 25th, 2015
NANOPOSTER 2015 - 5th Virtual Nanotechnology Conference - call for abstracts January 24th, 2015
Nanosensor Used for Simultaneous Determination of Effective Tea Components January 24th, 2015
Rice's Naomi Halas to direct Smalley Institute: Optics pioneer will lead Rice's multidisciplinary science institute January 15th, 2015
SUNY Board Appoints Dr. Alain Kaloyeros as Founding President of SUNY Polytechnic Institute January 13th, 2015
Blend Therapeutics Appoints Distinguished Physician Scientist, Dennis Ausiello, MD, to Board of Directors January 8th, 2015
QD Vision Receives New Funding Round to Meet Growing Demand for Quantum Dot Technology: Industry Veteran Steve Ward Named Executive Chairman January 5th, 2015